The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...
Zacks.com on MSN1 天
STXS Stock Up Post NMPA Nod for Cardiovascular Care With MagbotStereotaxis, Inc. STXS and Shanghai MicroPort EP Medtech Co., Ltd. announced the receipt of regulatory approval from China’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈